Free Trial
NASDAQ:BPTSY

Biophytis (BPTSY) Stock Price, News & Analysis

$3.05 0.00 (0.00%)
(As of 12/20/2024 ET)

About Biophytis Stock (NASDAQ:BPTSY)

Key Stats

Today's Range
$3.05
$3.05
50-Day Range
$2.82
$4.14
52-Week Range
$2.82
$34.24
Volume
2 shs
Average Volume
4,126 shs
Market Capitalization
$1.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. Its therapeutics focuses on targeting and activating key biological resilience pathways that could protect against and counteract the effects of the multiple biological and environmental stresses including inflammatory, oxidative, metabolic, and viral stresses that lead to age-related diseases. The company's lead drug candidate is Sarconeos (BIO101), an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and Duchenne muscular dystrophy (DMD), as well as in Phase 2/3 clinical study for the treatment of severe respiratory failure in patients suffering from COVID-19. It also develops Macuneos (BIO201), an orally administered small molecule for the treatment of retinal diseases, including dry age-related macular degeneration (AMD) and Stargardt disease. Biophytis SA has a collaboration agreement with AFM-Telethon for the development of its Sarconeos (BIO101) for the treatment of DMD. The company was incorporated in 2006 and is headquartered in Paris, France.

Receive BPTSY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biophytis and its competitors with MarketBeat's FREE daily newsletter.

BPTSY Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

BPTSY Stock Analysis - Frequently Asked Questions

Biophytis' stock was trading at $8.50 at the start of the year. Since then, BPTSY shares have decreased by 64.1% and is now trading at $3.05.
View the best growth stocks for 2024 here
.

Shares of BPTSY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

Today
12/22/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:BPTSY
Fax
N/A
Employees
22
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($16.18) per share

Miscellaneous

Free Float
338,000
Market Cap
$1.07 million
Optionable
N/A
Beta
1.17
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

This page (NASDAQ:BPTSY) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners